Research and development

Researchers have uncovered the chameleon-like power of certain cyanobacteria.

Finding genes linked to autism could help doctors choose the best intervention for young children when they are diagnosed and may lead to better screening tools.

Making high-quality 2D crystals for the electronics of tomorrow has been a challenge, but new research could be a big step forward.

"Pulsed light sintering of nanomaterials enables really fast manufacturing of flexible devices for economies of scale."

Zealand Pharma will use the proprietary peptide technology and world-leading expertise of UQ's Institute for Molecular Bioscience (IMB), as well as expertise from Flinders University in South Australia.

Though revolutionary, the "molecular scissors" called CRISPR-Cas9 can't cut RNA. Scientists think NmeCas9 is the answer.

"Our discovery could lead to earlier diagnosis and intervention."

Imagine going to the store for some chocolate, but not finding any. Researchers are doing some genetic sleuthing to prevent that from happening.

For decades, astronomers have been searching distant exoplanets for signs of life, mostly looking for water. But would this new approach work better?

Cockroaches are inspiring engineers to build robots that can scuttle through rubble after an earthquake or explore the surface of another planet.

Nielsen (NYSE: NLSN) and Dollar General (NYSE: DG), one of the nation's largest and fastest-growing retailers, announced an expansion of their longstanding strategic relationship.

This decision advances Lonza's strategy of being one of the world’s leading, integrated, value-added solutions providers along the healthcare continuum.

Diarrheal diseases are one of the leading causes of childhood mortality globally, resulting in approximately 525,000 deaths each year and cryptosporidiosis is the second leading cause of infectious diarrhea in children under 2 years of age.

Neanderthals had the brains to make complex tools but never quite got the hang of drawing on walls. 

Researchers have found a structure on the small viruses that deliver gene therapy that makes them better at crossing from the bloodstream into the brain.